- Home
- ELMD vs NVCT Comparison
ELMD vs NVCT Comparison
Compare ELMD & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- NVCT
- Stock Information
- Founded
- ELMD 1992
- NVCT 2020
- Country
- ELMD United States
- NVCT United States
- Employees
- ELMD N/A
- NVCT N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- ELMD Health Care
- NVCT Health Care
- Exchange
- ELMD Nasdaq
- NVCT Nasdaq
- Market Cap
- ELMD 201.5M
- NVCT 167.0M
- IPO Year
- ELMD 2010
- NVCT 2022
- Fundamental
- Price
- ELMD $26.71
- NVCT $6.08
- Analyst Decision
- ELMD Strong Buy
- NVCT Strong Buy
- Analyst Count
- ELMD 2
- NVCT 3
- Target Price
- ELMD $36.00
- NVCT $15.33
- AVG Volume (30 Days)
- ELMD 49.5K
- NVCT 88.1K
- Earning Date
- ELMD 11-12-2025
- NVCT 11-04-2025
- Dividend Yield
- ELMD N/A
- NVCT N/A
- EPS Growth
- ELMD 30.89
- NVCT N/A
- EPS
- ELMD 0.94
- NVCT N/A
- Revenue
- ELMD $66,218,999.00
- NVCT N/A
- Revenue This Year
- ELMD $14.47
- NVCT N/A
- Revenue Next Year
- ELMD $10.33
- NVCT N/A
- P/E Ratio
- ELMD $28.21
- NVCT N/A
- Revenue Growth
- ELMD 16.05
- NVCT N/A
- 52 Week Low
- ELMD $17.73
- NVCT $4.44
- 52 Week High
- ELMD $35.56
- NVCT $11.52
- Technical
- Relative Strength Index (RSI)
- ELMD 58.15
- NVCT 50.21
- Support Level
- ELMD $24.29
- NVCT $5.86
- Resistance Level
- ELMD $28.00
- NVCT $6.21
- Average True Range (ATR)
- ELMD 1.09
- NVCT 0.31
- MACD
- ELMD 0.20
- NVCT 0.01
- Stochastic Oscillator
- ELMD 62.79
- NVCT 64.12
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.